Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Gritstone bio shares target slashed, retains Buy rating

EditorNatashya Angelica
Published 04/02/2024, 02:27 PM

On Tuesday, BTIG adjusted its outlook on Gritstone bio (NASDAQ:GRTS), significantly reducing the stock price target to $3.00 from the previous $20.00, yet maintaining a Buy rating on the stock. The firm's decision follows an evaluation of interim results from Gritstone's Granite program, which indicated a trend toward improvement in progression-free survival (PFS) among all treated patients.

Specifically, the data revealed a hazard ratio (HR) of 0.82 in all treated patients and a more pronounced improvement in high-risk patients, with an HR of 0.52 and median PFS extending from 7 to 12 months.

Despite these findings, the lack of a clear separation in the PFS curve and the absence of a correlation between PFS improvement and ctDNA molecular response rate or RECIST response rate in patients treated with the vaccine compared to those receiving chemotherapy led to a cautious stance.

The analyst noted that the interim results provide limited assurance in de-risking the Granite program. The firm acknowledged the potential for more favorable data as it matures, yet the current results have prompted a reduction in the probability of success (POS) estimate from 65% to 30%.

The mature PFS data, expected in the third quarter of 2024, along with overall survival (OS) data anticipated in the first half of 2025, could still demonstrate positive PFS outcomes. Still, the analyst emphasized that the interim data currently do not significantly mitigate the perceived risks associated with the program.

This reassessment of risk and tempered expectations have led to the lowered price target for Gritstone bio's shares.

InvestingPro Insights

Following the recent assessment by BTIG, it is worth considering the financial health and market performance of Gritstone bio (NASDAQ:GRTS) through InvestingPro insights. Real-time data indicates that Gritstone has a market cap of approximately $122.58M and is trading near its 52-week low, with a previous close price of $2.35.

Despite the significant potential seen in their Granite program, the company is not expected to be profitable this year, with a negative P/E ratio of -1.04, reflecting the challenges ahead.

InvestingPro Tips suggest that analysts have revised their earnings upwards for the upcoming period, indicating some optimism in the company's future performance. Still, they also note that Gritstone is quickly burning through cash, which could be of concern to investors.

Moreover, with the company suffering from weak gross profit margins and analysts anticipating a sales decline in the current year, the financial outlook requires careful consideration. For those looking for a more in-depth analysis, InvestingPro offers additional tips, with the mention that there are 12 more tips available for Gritstone on their platform.

To explore these insights and tips further, and to make the most informed investment decisions, readers may use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro. With the next earnings date on May 9, 2024, staying updated on Gritstone's financial and market performance will be crucial for investors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.